Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 1/20 | 0.46 |
| ▸ | CETP | P11597 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | FEN1 | P39748 | 1/20 | 0.39 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | KDM5A | P29375 | 1/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.38 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.38 |
| ▸ | DAO | P14920 | 1/20 | 0.38 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21751247 | 0.79 | PTPN1 (0.41) | CETPPOLBPTPN1KCNN4EPHX1 | |
| SCHEMBL3074468 | 0.73 | HSD17B10 (0.55) | DCUN1D1 | |
| SCHEMBL5526402 | 0.72 | CHRM2 (0.50) | CETPEPHX1CHRM2CHRM1CHRM3 | |
| SCHEMBL5526398 | 0.72 | EPHX1 (0.48) | CETPEPHX1ROCK1ROCK2CHRM2 | |
| SCHEMBL5367845 | 0.71 | EPHX1 (0.46) | CETPEPHX1CHRM2CHRM1CHRM3 | |
| SCHEMBL28251101 | 0.71 | CTSA (0.53) | CTSA | |
| SCHEMBL5009648 | 0.69 | DAO (0.55) | CETPCHRM2CHRM1CHRM3DAO | |
| SCHEMBL6054525 | 0.69 | CETP (0.43) | CETPEPHX1FEN1CHRM2CHRM1 | |
| SCHEMBL178310 | 0.68 | CHRM2 (0.55) | CETPCHRM2CHRM1CHRM3DAO | |
| SCHEMBL19062249 | 0.68 | CETP (0.53) | CETPROCK1ROCK2CHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200060276-A1 | THIAZOLE COMPOUND AND HERBICIDE | OAT AGRIO CO., LTD. (JP) | 2020-02-27 | — | — | US | disclosed |
| US-20200060276-A1 | THIAZOLE COMPOUND AND HERBICIDE | OAT AGRIO CO., LTD. (JP) | 2020-02-27 | — | — | US | disclosed |
| CN-110325518-A | Thiazolium compounds and herbicide | 日本欧爱特农业科技株式会社 | 2019-10-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200060276-A1 | THIAZOLE COMPOUND AND HERBICIDE | OR10J3, OXSR1, OXER1 | CTSA 4422/4885CETP 4708/4885POLB 4571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.